Stephen Hoffman - Chief Executive Officer, Aerpio Pharmaceuticals, Inc

As of May 16, 2019


Stephen Hoffman Net Worth

  • Net worth is estimated to be at least $68.54M
  • Owns at least 31,967 units of Aerpio Pharmaceuticals, Inc stock

Stephen Hoffman Trading

  • Largest purchase of shares was 31,967 units , worth over $64.14K on November 14, 2018
  • In total has made about 5 transactions over 2 years
  • Usually trades in February, December, November, May and April, with the busiest year in 2019 and 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Stephen Hoffman Mailing Address

  • Mailing address is C/o Skyline Ventures 525 University Ave., Suite 1350 Palo Alto CA 94301 CA

Aerpio Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Option Awards
Bonus
Other Earnings Plans or Compensations
Other Compensation
Total
Joseph Gardner 2020 $432,600 $48,427 $210,000 $108,150 $1,646 $590,823
Joseph Gardner 2019 $420,000 $510,423 - $199,500 $1,069 $1,130,992
Regina Marek 2020 $278,100 $29,057 $120,000 $48,668 $350 $356,175
Regina Marek 2019 $244,643 $168,866 - $71,708 $373 $485,590
Kevin Peters 2020 $370,800 $40,304 $180,000 $74,160 $1,003 $486,267
Kevin Peters 2019 $360,000 $450,200 - $136,800 $1,069 $948,069
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1422142/000156459021032185/arpo-def14a_20210722.htm

Aerpio Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 21,400 units sold on December 10, 2020 by Orbimed Advisors Llc and Orbimed Capital GP V Llc worth over $41.94K
  • In the last 2 years, insiders at Aerpio Pharmaceuticals, Inc sold an estimated value of $1.84M and bought an estimated value of $14.39M
  • The most active traders are Muneer Satter, Director,  Ag Novartis,  and Novartis Bioventures Ltd
  • Insider trading is most common in June, with the busiest year in 2019

Aerpio Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1